Group 1 - The A-share market for monoclonal antibody concepts is active, with companies like Sai Sheng Pharmaceutical and Hainan Hai Pharmaceutical seeing gains of over 9% [1] - Other stocks such as Yiling Pharmaceutical, Zhongyuan Qihua, and Fudan Zhangjiang also experienced upward movement [1] - The collaboration between Hong Kong's cornerstone pharmaceutical company and European firm Gentili regarding Sugli monoclonal antibody is expected to boost the innovative drug market [1]